CNO-PA — CNO Financial Group, Inc. 5.125

CNO Financial Group, Inc. Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Operating Earnings per Share (EPS): Increased 33% to $1.05; up 42% excluding significant items.
• Sales Growth: Achieved fifteenth consecutive quarter of sales growth; total new annualized premiums rose 11%.
• Book Value per Share: Increased 5% to $38.98 (excluding AOCI).
• Expense Ratio: Improved to 18.9%, with expectations of normalization over the year.
• Return on Equity (ROE): Trailing twelve-month ROE was 13.1%, 12.2% excluding significant items.
• Shareholder Returns: Returned $77 million to shareholders through dividends and share repurchases.

2. Strategic Updates and Business Highlights:

• Consumer Division: Strong performance with Life and Health New Annualized Premiums (NAP) up 9%. Medicare policies sold increased 24%, with Medicare supplement NAP up 53%.
• Worksite Division: Life and Health NAP rose 22%, marking the sixteenth consecutive quarter of sales growth. Life insurance grew 56%, and hospital indemnity insurance surged 121%.
• Agent Growth: Producing agent count increased 3%, with registered agent count up 7%. Agent productivity and retention remain strong.
• Technology Investments: Continued focus on enhancing efficiency and customer experience through technology, including AI applications in customer service.

3. Forward Guidance and Outlook:

• CNO Financial affirmed its original guidance for 2026, citing strong underlying performance but acknowledging macroeconomic volatility.
• Plans to refine projections later in the year, with an intention to increase 2027 ROE ambitions beyond the current 12% target.
• Anticipated rate increases in the Medicare supplement business expected to improve profitability in the latter half of 2026.

4. Bad News, Challenges, or Points of Concern:

• Medicare Advantage Market: Industrywide MA enrollment growth slowed significantly, leading to increased competition and potential customer churn.
• Claims Experience: Some adverse claims experience in the Medicare supplement business noted, though mitigated by expected rate increases.
• Investment Environment: Volatility in credit markets and lower equity market performance impacted the risk-based capital ratio, though recovery is anticipated.

5. Notable Q&A Insights:

• Medicare Supplement Pricing: Rate increases filed for both closed and open blocks are expected to take effect in 2026, with full impact visible by Q4 2026.
• Expense Management: The favorable expense ratio in Q1 is expected to normalize, but growth in the business may provide leverage for continued efficiency.
• Long-Term Care Performance: Favorable claims experience noted, with expectations for continued stability and potential margin improvements.
• Investment Strategy: CNO remains cautious in the credit markets, focusing on high-quality investments and avoiding unnecessary risks despite favorable opportunities.

Overall, CNO Financial Group demonstrated strong financial performance in Q1 2026, with positive growth across divisions and a disciplined approach to capital management, while navigating challenges in the Medicare market and investment landscape.